Taipei Pharmacy Corp. Intel.

Country/Region: China     State/Province: Taiwan

Main Products: Ephedrine, Ketamine, Ecstasy

Company Introduction
ephedrine, ketamine, ecstasy
Company Overview

Business Type: Exporter, Buying House

Year Established: 2005

Employees: 101 - 200 People

Plant Area: 30,000-50,000 square meters

Business Information

Main Markets: South America 11% Africa 8% Eastern Asia 11% Domestic Market 10% North America 9% Eastern Europe 9% Southern Europe 12% Mid East 12% Northern Europe 10% Oceania 8%

Trade Capacity: FOB, FAS, CPT

Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered

Nearest Port: Taipei

Trade & Financial Information

Annual Revenue: US$10 Million - US$50 Million

Total Revenue: confidential

Export Revenue: US$2.5 Million - US$5 Million

Annual Output: confidential

Registered Capital: US$10 Million - US$50 Million

Export Percentage: 51% - 60%

Payment Modes: USD, EUR, CHF

Lead Time: 21 days

Import/Export Mode: LLC (Limited Liability Corp)

Product Showcase
ephedrine
ketamine
ecstasy

CL-Link > Health & Medicines in China Health & Medicines in Taiwan Medicines in China Medicines in Taiwan Pharmaceutical Drug in China Pharmaceutical Drug in Taiwan